Lantheus Holdings, Inc (LNTH) Stock Price

LNTHStock

$100.77+81.57%52W

Market Cap$6.58B

P/E28.20x

PEG Ratio0.59

Div yield—

Beta-0.04

LNTH Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)24.97%

Price vs S&P 500 (4W)-1.96%

PEG Ratio0.59

VGM Score62.74

P/E Ratio (Annual)28.20x

P/CF (Annual)16.88x

Book Value / Share (Quarterly)$20.10

P/TBV (Annual)12.02x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)18.13%

Cash Flow / Share (Quarterly)$5.94

Price vs S&P 500 (YTD)38.60%

Gross Margin (TTM)60.98%

Net Profit Margin (TTM)17.69%

EPS (TTM)$4.13

10-Day Avg Trading Volume1.44M

EPS Excl Extra (TTM)$4.13

Revenue Growth (5Y)35.35%

EPS (Annual)$3.41

ROI (Annual)14.08%

Gross Margin (Annual)61.10%

Net Profit Margin (5Y Avg)9.39%

Cash / Share (Quarterly)$9.09

P/E Basic Excl Extra (TTM)23.92x

Revenue Growth QoQ (YoY)2.68%

EPS Growth (5Y)40.71%

P/E Normalized (Annual)28.20x

ROA (Last FY)10.49%

Revenue Growth TTM (YoY)2.35%

EBITD / Share (TTM)$6.73

ROE (5Y Avg)16.22%

Operating Margin (TTM)23.25%

Cash Flow / Share (Annual)$5.48

P/B Ratio5.02x

P/B Ratio (Quarterly)5.51x

Net Income / Employee (Annual)$195,800

EV / Revenue (TTM)4.22x

Net Interest Coverage (TTM)53.46x

ROA (TTM)11.89%

EPS Growth QoQ (YoY)-0.79%

EV / EBITDA (TTM)14.58x

EPS Incl Extra (Annual)$3.41

Current Ratio (Annual)2.70x

Quick Ratio (Quarterly)2.89x

3-Month Avg Trading Volume1.26M

52-Week Price Return81.57%

EV / Free Cash Flow (Annual)18.54x

P/E Incl Extra (TTM)23.92x

Revenue / Employee (TTM)$1,304,500

Tangible BV / Share (Quarterly)$9.54

P/S Ratio (Annual)4.27x

Asset Turnover (Annual)0.69x

52-Week High$111.86

Operating Margin (5Y Avg)13.56%

EPS Excl Extra (Annual)$3.41

CapEx CAGR (5Y)23.62%

Tangible BV CAGR (5Y)21.57%

26-Week Price Return36.90%

Quick Ratio (Annual)2.51x

13-Week Price Return1.15%

Total Debt / Equity (Annual)0.52x

Current Ratio (Quarterly)3.06x

Enterprise Value$6.56B

Revenue / Share Growth (5Y)29.13%

Asset Turnover (TTM)0.67x

Book Value / Share Growth (5Y)17.03%

Revenue / Employee (Annual)$1,292,200

Inventory Turnover (Annual)9.04x

Pretax Margin (Annual)20.35%

Cash / Share (Annual)$5.56

3-Month Return Std Dev30.25%

Gross Margin (5Y Avg)59.21%

Net Income / Employee (TTM)$230,800

EBITDA CAGR (5Y)79.40%

EBITDA Interim CAGR (5Y)46.03%

ROE (Last FY)21.43%

Net Interest Coverage (Annual)9.93x

EPS Basic Excl Extra (Annual)$3.41

P/FCF (TTM)16.98x

Receivables Turnover (TTM)4.51x

EV / Free Cash Flow (TTM)16.93x

Total Debt / Equity (Quarterly)0.44x

EPS Incl Extra (TTM)$4.13

Receivables Turnover (Annual)4.53x

ROI (TTM)15.70%

P/S Ratio (TTM)4.23x

Pretax Margin (5Y Avg)13.07%

Revenue / Share (Annual)$22.52

Tangible BV / Share (Annual)$5.68

Forward P/E17.10x

Free OCF CAGR (5Y)146.38%

Price vs S&P 500 (52W)63.01%

P/E Ratio (TTM)23.92x

EPS Growth TTM (YoY)9.79%

Year-to-Date Return51.42%

5-Day Price Return-0.03%

EPS Normalized (Annual)$3.41

ROA (5Y Avg)7.99%

Net Profit Margin (Annual)15.15%

Month-to-Date Return1.13%

Cash Flow / Share (TTM)$2.32

EBITD / Share (Annual)$5.57

EPS Growth (3Y)104.76%

Operating Margin (Annual)20.16%

LT Debt / Equity (Annual)0.52x

P/CF (TTM)15.96x

ROI (5Y Avg)9.66%

P/E Excl Extra (TTM)23.92x

LT Debt / Equity (Quarterly)0.43x

EPS Basic Excl Extra (TTM)$4.13

P/TBV (Quarterly)11.60x

P/B Ratio (Annual)4.05x

Inventory Turnover (TTM)10.15x

Pretax Margin (TTM)23.32%

Book Value / Share (Annual)$16.87

Price vs S&P 500 (13W)-0.80%

Net Margin Growth (5Y)17.41%

Beta-0.04x

P/FCF (Annual)18.60x

Revenue / Share (TTM)$23.05

ROE (TTM)23.27%

52-Week Low$49.67

vGradeC

gGradeB

mGradeB

vgmGradeB

LNTH Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	$1.30	$1.55	+18.90%(+$0.25)
Q1 2026	May 7, 2026	$1.23	$1.46	+18.78%(+$0.23)
Q4 2025	Feb 26, 2026	$1.17	$1.67	+42.92%(+$0.50)
Q3 2025	Nov 6, 2025	$1.27	$1.27	+0.24%(+$0.00)
Q2 2025	Aug 6, 2025	$1.68	$1.57	-6.29%(-$0.11)

LNTH Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.11

4.05

Industry Peers — In Vitro Diagnostics(18)

Symbol	Value Score	Growth Score	Momentum Score	Price
LNTHLantheus Holdings, Inc	C	B	B	$100.77
IDXXIdexx Laboratories Inc	D	B	C	$554.99
CLDXCelldex Therapeutics, Inc	F	F	B	$39.12
NEOGNeogen Corp	C	C	B	$11.66
NTLAIntellia Therapeutics, Inc	D	D	C	$12.87
QDELQuidelOrtho Corporation Common Stock	C	C	C	$14.74
ACHVAchieve Life Sciences, Inc.	F	F	A	$8.10
TKNOAlpha Teknova, Inc. Common Stock	D	C	B	$7.12
NNNNAnbio Biotechnology Class A Ordinary Shares	F	B	F	$7.67
MYGNMyriad Genetics Inc	B	C	D	$3.16
IMDXInsight Molecular Diagnostics Inc. Common Stock	F	D	C	$4.13
ICCCImmucell Corp	C	B	B	$9.94
QCLSQ/C Technologies, Inc. Common Stock	C	—	F	$2.35
TRIBTrinity Biotech plc	B	D	F	$9.68
BMRABIOMERICA INC	B	D	C	$2.14
VNRXVolitionRx Limited	B	A	F	$0.45
CDIOCardio Diagnostics Holdings Inc. Common stock	—	C	D	$1.85
VRAXVirax Biolabs Group Limited Ordinary Shares	—	B	F	$2.82
CDIOWCardio Diagnostics Holdings Inc. Warrant	—	—	B	$0.02

About Lantheus Holdings, Inc

Lantheus Holdings is a radiopharmaceutical company that develops and markets imaging agents and diagnostic solutions focused on oncology and precision diagnostics. Its products are used by physicians and technologists in clinical settings to identify and monitor disease. The company operates primarily in the United States, with international distribution networks in Europe, Canada, Australia, Asia-Pacific, and Latin America.